FABP1 and psoriasis: Based on this study, it may be suspected that FABP-1 could be considered a marker of metabolic complications in psoriasis and help in indicating patients who could be more prone to such disorders, which could be followed by the earlier introduction of specialized examinations and treatment in this group.